As cancer drug shortages persist, ASCO official urges congressional action at hearing

A year into a dire shortage of essential cancer medicines in the U.S., the American Society of Clinical Oncologists (ASCO) is again pushing Congress to act to end the crisis. | The oncology drug supply crisis has entered its second year, and doctors still face “impossible choices” without access to standard-of-care therapies, ASCO’s chief medical officer, Dr. Julie Gralow, testified this week. At a congressional hearing, Gralow proposed recommendations that could help ease the situation.

No Byline Policy

Editorial Guidelines

Corrections Policy

Source